Edition:
United Kingdom

Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd (0874.HK)

0874.HK on Hong Kong Stock

21.50HKD
15 Feb 2018
Change (% chg)

HK$0.60 (+2.87%)
Prev Close
HK$20.90
Open
HK$20.90
Day's High
HK$21.50
Day's Low
HK$20.90
Volume
420,000
Avg. Vol
2,260,088
52-wk High
HK$27.65
52-wk Low
HK$19.00

Latest Key Developments (Source: Significant Developments)

Guangzhou Baiyunshan Pharmaceutical Holdings unit receives GMP certificate
Friday, 5 Jan 2018 

Jan 5 (Reuters) - Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd <600332.SS>:Says Guangzhou-based pharmacy unit received goods manufacture practice (GMP) certificate from Guangdong Food and Drug Administration .Certificate issued to oral dosage, Cephalospora capsule, sirup, granules and tablet manufactured by the unit and the valid period is until Dec. 19, 2022.  Full Article

Guangzhou Baiyunshan Pharmaceutical Holdings says result of arbitration
Tuesday, 26 Dec 2017 

Dec 26 (Reuters) - Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd <600332.SS>:Says it received arbitral awards regarding arbitration filed by the co against GOLDEN FORCE PHARMACY LIMITED, from South China International Economic and Trade Arbitration Commission .According to the result of arbitration, GOLDEN FORCE PHARMACY LIMITED will transfer 98.4 million shares(48 percent stake) of Guangzhou Wanglaoji Pharmaceutical Company Limited to the co, at the price of 3.75 yuan per share, for 368.9 million yuan in total .Says GOLDEN FORCE PHARMACY LIMITED will bear partial arbitration fees and other fees .  Full Article

Guangzhou Baiyunshan Pharmaceutical To Acquire Stake In Guangzhou Pharma
Friday, 22 Dec 2017 

Dec 22 (Reuters) - Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd <600332.SS>0874.HK::SAYS IT PLANS TO ACQUIRE 30 PERCENT STAKE IN GUANGZHOU PHARMA FOR 1.09 BILLION YUAN ($165.84 million).SAYS TO OWN 80 PERCENT STAKE OF GUANGZHOU PHARMA AFTER THE TRANSACTION.SAYS SELLER HAS THE OPTION TO SELL THE REMAINING 20 PERCENT STAKE IN GUANGZHOU PHARMA.  Full Article

Guangzhou Baiyunshan Pharmaceutical Updates On Suspension Of Trading Of A Shares
Monday, 4 Dec 2017 

Dec 4 (Reuters) - Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd <600332.SS>::REFERS TO ANNOUNCEMENT OF COMPANY DATED 30 OCTOBER IN RELATION TO SUSPENSION OF TRADING OF A SHARES.‍AS AT 4 DEC, PROPOSED ACQUISITION IS IN PROGRESS​.GIVEN UNCERTAINTY REGARDING PROPOSED PURCHASE, CO'S A SHARES TO CONTINUE TO BE SUSPENDED.  Full Article

Guangzhou Baiyunshan Pharmaceutical Updates On Suspension Of A Shares
Wednesday, 29 Nov 2017 

Nov 29 (Reuters) - Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd <600332.SS>::‍CO EXPECTS THAT TRADING IN A SHARES WILL BE SUSPENDED FOR NOT MORE THAN ONE MONTH FROM 30 NOVEMBER 2017​.‍EXPECTS IT WON'T BE ABLE TO DISCLOSE PRELIMINARY SCHEME OF PROPOSED ACQUISITION BY 30 NOVEMBER 2017 AS SCHEDULED​.  Full Article

Guangzhou Baiyunshan Pharmaceutical Holdings unit signs strategic cooperation framework agreement
Tuesday, 28 Nov 2017 

Nov 28(Reuters) - Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd <600332.SS> ::Says its unit signed a biomedical industry strategic cooperation framework agreement with Shanghai-based biotechnology firm, to cooperate in biopharmaceutical industry field .  Full Article

Guangzhou Baiyunshan Pharmaceutical says ‍trading in A shares to continue to be suspended​
Monday, 13 Nov 2017 

Nov 13 (Reuters) - Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd <600332.SS>::Trading in co's A shares will continue to be suspended​.  Full Article

Guangzhou Baiyunshan Pharmaceutical says ‍trading in A shares to be suspended from 31 Oct
Monday, 30 Oct 2017 

Oct 30 (Reuters) - Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd <600332.SS>::Trading in co's A shares on Shanghai Stock Exchange will be suspended from 31 Oct.Is contemplating a significant transaction which may involve major asset restructuring​.  Full Article

Guangzhou Baiyunshan Pharmaceutical's 9-month net profit up 40.6 pct
Sunday, 22 Oct 2017 

Oct 22 (Reuters) - Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd <600332.SS>:Says its 9-month net profit up 40.6 percent y/y at 1.49 billion yuan ($225.13 million).  Full Article

Guangzhou Baiyunshan Pharmaceutical Holdings says Jan-Sept net profit at RMB 1.06bln
Tuesday, 25 Oct 2016 

Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd <600332.SS>- : 9 month income from operation at RMB 15.54 billion versus RMB 15.07 billion .Jan-Sept net profit RMB 1.06 billion versus RMB 960.0 million a year ago.  Full Article